Printer Friendly Version

Send to a Friend

Biovalve Technologies, a manufacturer of drug-delivery systems, will expand its 23,500-sf research and development facility in Westborough, Mass., by 40,000 sf to 45,000 sf. Adding manufacturing capacity, the expansion will begin by spring of 2006 with initial clinical and commercial production beginning at the facility by the end of the year. The project represents an investment of $8 million.